The detailed information for PTAB case with proceeding number IPR2018-00119 filed by Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. against Gilead Pharmasset LLC et al. on Oct 25, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2018-00119
Filing Date
Oct 25, 2017
Petitioner
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al.
Respondent
Gilead Pharmasset LLC et al.
Status
Institution Denied
Respondent Application Number
12053015
Respondent Tech Center
1600
Respondent Patent Number
7964580
Institution Decision Date
May 4, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Aug 3, 2018PAPERBOARD

Petitioner's Request for Refund of Post-Institution Fees

Jul 13, 2018PAPERPETITIONER

Denying Petitioner's Request for Rehearing 37 C.F.R. sec. 42.71

Jul 3, 2018PAPERBOARD

Petitioner's Request for Rehearing

Jun 4, 2018PAPERPETITIONER

EPO Decision

Jun 4, 2018EXHIBITPETITIONER

Decision Denying Institution of Inter Partes Review

May 4, 2018PAPERBOARD

Certificate of Correction

May 4, 2018EXHIBITBOARD

Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph

Feb 8, 2018EXHIBITPATENT OWNER

FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir

Feb 8, 2018EXHIBITPATENT OWNER

HARVONI¿¿ label

Feb 8, 2018EXHIBITPATENT OWNER

Clofarabine: From Design to Approval.

Feb 8, 2018EXHIBITPATENT OWNER

Hepatitis C Deserves the Attention

Feb 8, 2018EXHIBITPATENT OWNER

FDA Approves Gilead¿¿¿s Hepatitis C Drug

Feb 8, 2018EXHIBITPATENT OWNER

Discovery of a ¿¿-D-2¿¿¿-Deoxy-2¿¿¿-¿¿-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus

Feb 8, 2018EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

Feb 8, 2018PAPERPATENT OWNER

Nucleoside Analog Inhibitors of Hepatitis C Virus Replication

Feb 8, 2018EXHIBITPATENT OWNER

Hepatitis C Killing More Americans than HIV: Studies

Feb 8, 2018EXHIBITPATENT OWNER

America¿¿¿s Overspend: How the Pharmaceutical Patent Problem is Fueling High Drug Prices

Feb 8, 2018EXHIBITPATENT OWNER

I-MAK: Our People

Feb 8, 2018EXHIBITPATENT OWNER

Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection

Feb 8, 2018EXHIBITPATENT OWNER

F.D.A. Approves Pill to Treat Hepatitis C

Feb 8, 2018EXHIBITPATENT OWNER

United States Provisional Application Serial No. 60/909,315

Feb 8, 2018EXHIBITPATENT OWNER

United States Provisional Application Serial No. 60/982,309

Feb 8, 2018EXHIBITPATENT OWNER

Pro-Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates

Feb 8, 2018EXHIBITPATENT OWNER

Prodrugs of Phosphates, Phosphonates, and Phosphinates

Feb 8, 2018EXHIBITPATENT OWNER

Patent Owner's Mandatory Notices

Nov 9, 2017PAPERPATENT OWNER

Patent Owner Power of Attorney

Nov 9, 2017PAPERPATENT OWNER

Notice of Accord Filing Date

Nov 8, 2017PAPERBOARD

Power of Attorney

Oct 25, 2017PAPERPETITIONER

Clark 147

Oct 25, 2017EXHIBITPETITIONER

Perrone

Oct 25, 2017EXHIBITPETITIONER

U.S. Patent No. 7,964,580

Oct 25, 2017EXHIBITPETITIONER

Curriculum Vitae of Joseph M. Fortunak, Ph.D.

Oct 25, 2017EXHIBITPETITIONER

Sofia

Oct 25, 2017EXHIBITPETITIONER

Ma

Oct 25, 2017EXHIBITPETITIONER

Clark 2005

Oct 25, 2017EXHIBITPETITIONER

McGuigan 327

Oct 25, 2017EXHIBITPETITIONER

Wagner

Oct 25, 2017EXHIBITPETITIONER

Prusoff

Oct 25, 2017EXHIBITPETITIONER

McGuigan 2006

Oct 25, 2017EXHIBITPETITIONER

McGuigan 1994

Oct 25, 2017EXHIBITPETITIONER

Cahard

Oct 25, 2017EXHIBITPETITIONER

Petition for Inter Partes Review

Oct 25, 2017PAPERPETITIONER

Declaration of Joseph M. Fortunak, Ph.D.

Oct 25, 2017EXHIBITPETITIONER